Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Somavaratan

Generic Name: Somavaratan

Drug Type: Biotech

CAS Number: 1448335-08-7

Unique Ingredient Identifier: 4Y05SI704S

Overview

Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone Deficiency.

Background

Somavaratan has been used in trials studying the treatment of Growth Disorders and Adult Growth Hormone Deficiency.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Phase 3

Terminated

Posted: 2017/05/09

Sponsor:Versartis Inc.

ID:NCT03145831

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Phase 2

Terminated

Posted: 2016/03/25

Sponsor:Versartis Inc.

ID:NCT02719990

Versartis International Trial in Adults With Long-Acting Growth Hormone

Phase 2

Completed

Posted: 2015/08/18

Sponsor:Versartis Inc.

ID:NCT02526420

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Phase 2

Terminated

Posted: 2015/04/09

Sponsor:Versartis Inc.

ID:NCT02413138

Long-Acting Growth Hormone in Children Compared to Daily rhGH

Phase 3

Completed

Posted: 2015/01/15

Sponsor:Versartis Inc.

ID:NCT02339090

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy